BLUEJETNSEBlue Jet Healthcare Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 16 Jun, 2025 · 16:26 IST

Blue Jet Healthcare Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.1%Reaction day
₹937.90
prior close
₹938.55
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.7%-2.4% vs market
Pharmaceuticals peers, median of 150sector-1.5%-1.6% vs sector

On the reaction day the stock moved 2.4 pts less than Nifty Smallcap 250 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.0
15m
+0.0
30m
+0.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.1-0.7-2.4-1.5-1.6
Next day
-6.1-0.9-5.3-2.0-4.1
2d
-9.1-2.8-6.4-3.5-5.7
3d
-7.0-2.2-4.8-2.8-4.2
4d
-8.6-1.4-7.2-2.8-5.8
5d
-7.7-0.7-7.0-2.3-5.3
1w
-7.5+1.2-8.6-1.5-5.9
15d
-6.7+2.2-9.0-0.4-6.3
1m
+3.7+4.3-0.6+2.1+1.6
2m
-16.8-2.4-14.4-4.0-12.8
3m
-25.4+1.0-26.4-1.8-23.6
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Blue Jet Healthcare Limited has announced the results of its postal ballot conducted via remote e-voting between May 16 and June 14, 2025. Shareholders approved a special resolution to raise funds in one or more tranches through the issuance of equity shares and/or other eligible securities. The resolution received overwhelming support with 99.87% of votes cast in favour (15,14,74,919 shares) and only 0.13% against (1,97,815 shares). Promoters voted 100% in favour, while public institutions voted 92.05% in favour and public non-institutions voted 93.24% in favour. Out of 63,501 shareholders on record date, 151,672,734 shares were polled representing 87.44% of total outstanding shares.

Likely market impact

This approval gives the company a green light to raise capital through equity or equity-linked instruments in the coming months. Shareholders should expect potential dilution depending on the size and structure of the eventual fundraise. The strong voting margin and promoter support signal confidence in the company's growth plans.